Dogecoin and Shiba Inu saw last-minute gains, but this token from a failed exchange was the best performer of the week with a 180% increase

Failed crypto lender Celsius Network’s native token CEL/USD was the biggest gainer last week, gaining 181% over seven days. The token's massive rally was largely fueled by a retail-focused short squeeze, with traders following the "#CELShortSqueeze" hashtag on Twitter.

Top Earners for the Week Ending August 15, 2022 (Data via CoinMarketCap) Cryptocurrency % change over 7 days (+/-) Maximum Value of All Time/Date Reached % change (+/-) from all-time high Celsius (CEL) +181% $$8.05 Jun 02, 2021 -48% Anker (ANKR) +40% $0.213 April 16, 2021 -77.9% Nexo (NEXO) +34% $4.07 May 12, 2021 -75% Shiba Inu (SHIB) +21.72% $0.00008616 on October 28, 2021 -81% Huobi (HT) +21% $39.66 January 30, 2019 -70%

Short press CEL

Retail traders have sent CEL on a gargantuan rally since the start of the short compression move last month. According to Benzinga Pro data, the CEL has increased by more than 440% in the last 30 days.

Binance invests in ANKR

The native Ankr protocol token ANKR/USD rose 50% on August 12 after crypto exchange Binance announced a strategic investment in the DeFi platform. Binance said the funds will be used to accelerate work on Ankr's remote procedure call (RPC) service and grow its Web3 developer suite.

At press time, ANKR was trading at $0.046, up 0.9% in the last 24 hours.

Nexo launches the Pro-Trading platform

Nexo NEXO/USD blockchain-based lending platform has launched a new trading platform for advanced cryptocurrency traders. At press time, NEXO was trading at $1.02, up 34% over the past seven days.

Meme Coin and Alt Season imminent?

Meme Shiba Inu coin SHIB/USD is up 37% in the last day alone, placing it among the best performing coins of the week. Dogecoin DOGE/USD also saw a 10% gain over the past day, prompting market participants to speculate that another season could be on the cards as Bitcoin BTC/USD and Ethereum ETH/USD recorded moderate gains.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Ad Disclosure: Rate information is obtained by Bankrate from listed institutions. Bankrate cannot guarantee the accuracy or availability of the rates shown above. Institutions may have different rates on their own websites than those displayed on Bankrate.com. The listings that appear on this page are from companies that this website receives compensation from, which may impact how, where and in which order products appear. This table does not include all companies or products available.

All rates are subject to change without notice and may vary by location. These quotes are from banks, savings and credit unions, some of which have paid for a link to their own websites where you can find additional information. Those who have a paid link are our advertisers. Those without a paid link are listings we obtain to enhance consumers' shopping experience and are not advertisers. To receive the